Solid lung tumors have a complex tumor microenvironment that creates barriers to drug delivery. Nanoparticle therapies can overcome these challenges.
- Why In Vivo Therapies Fail When We Treat Them Like Ex Vivo Ones
- 4 Opportunities For Advancing Drug Delivery
- In Vivo's Biggest Threat — Comparison To Old Models
- The Great Cell Therapy Reset: Solving The Industrial Math Of Living Drugs
- Conducting A Medical Device Stability Study: A Practical Guide
- Nanotechnology Drug Delivery: A Market Overview
- Combination: The Drug Delivery Word Of The Year For 2026
- In Vivo LNP-Engineered Cytokine-Armored CAR Cells For Solid Tumors
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Lyophilization vs. Liquid Formation: Why Lyo Offers Advantages
Lyophilization offers some alluring advantages in today’s complex market, but its challenges require innovation and expertise to surmount.
-
2R Vials And Deep Cold Storage - Determining Mechanical & CCI Performance
Review the implications of this study on the storage of sensitive molecules that require deep-cold storage and learn how 2R Fina glass vials are poised to enhance cold storage practices.
-
Selective Crystallization Of A Novel Polymorph
Discover how applied rigorous characterization standards and expert knowledge of critical water activity enabled the isolation of a previously undiscovered and uncharacterized polymorph.
-
Enabling Long Lasting Clinical Outcomes In Coronary Stenting
Polyester amides (PEAs) bring several desired and differentiating properties to drug-eluting stent (DES) applications for treating coronary artery disease (CAD).
-
The Importance Of An Analytical Testing Strategy
A proper and well-thought-out combination product testing strategy, rooted in applicable guidances in sync with scientifically sound methods, data capture, and reporting and retainment, is critical.
-
Which Testing Does An Effective Certificate Of Analysis Include?
Discerning mandatory testing from supplemental testing for early-stage injectable or IV-infusion therapies streamlines CoA creation and promotes regulatory compliance.
-
Maintaining Drug Bioavailability And Masking Taste With Microencapsulation
Several technologies are available for microencapsulating drugs. Finding the right CDMO to optimize a drug’s efficacy and manufacturing during formulation is integral to its clinical and commercial success.
-
Spray Drying To Enable New Inhaled Drug Products
The formulation and spray drying process can help manufacture a stable, highly respirable powder and deliver products that require a high drug load, a biologic, or rapid onset therapeutic.
-
Comparing Vial Container Closure Systems
Examine a case study where two 20mm vial CCSs were compared using the DeltaCube™ Modeling Platform and experimentally show the link between prediction and real performance.
-
Streamline Early-Stage Development To Reach The Clinic Faster
Early-stage development is an iterative process, continuously generating new data and insights to optimize the product based on emerging knowledge.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
DELIVERED BY DEGRAZIO
-
4 Opportunities For Advancing Drug Delivery
In this article, Fran DeGrazio identifies four prime opportunities for drug delivery developers to move the dial of innovation into 2026 and beyond. These avenues for advancement include diagnostics, patient tolerability, microdosing, and analytical methodologies.

